Search results
Results from the WOW.Com Content Network
Martin Shkreli (/ ˈ ʃ k r ɛ l i /; born March 17, 1983) is an American investor and businessman.Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.
Clockwise from top-left: OpenAI boss Sam Altman, venture capitalist Marc Andreessen, “Pharma Bro” turned AI entrepreneur Martin Shkreli, former OpenAI board member Elon Musk, and, in the ...
The U.S. Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli's challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving ...
The Lown Institute awards the Shkreli Awards named after Martin Shkreli for "worst examples of profiteering and dysfunction in health care". [32] In 2020 it was awarded to the Trump administration’s federal personal protective equipment (PPE) taskforce. [33]
What links here; Related changes; Upload file; Special pages; Permanent link; Page information; Cite this page; Get shortened URL; Download QR code
Martin Shkreli, the infamous “pharma bro” once convicted of securities fraud, has must to turn over all copies of what was supposed to be a multi-million-dollar, one-of-a-kind Wu Tang Clan ...
NEW YORK, March 5 (Reuters) - Former drug company executive Martin Shkreli may have to give up a Picasso and a one-of-a-kind Wu-Tang Clan album, after a U.S. judge on Monday ordered him to forfeit ...
NEW YORK (Reuters) -Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court on Tuesday ...